1. Home
  2. Companies
  3. Epistemix
Epistemix logoEP

Epistemix

About

Epistemix is a computational modeling company headquartered in Pittsburgh. It builds agent-based simulation software and generates synthetic population data, enabling organisations to model human behaviour and test interventions in uncertain scenarios.

The company's technology is applied across several sectors, including public health, life sciences, insurance, healthcare, government, and enterprise strategy. Its core technical domains span agent-based simulation, synthetic population data generation, data science, and advanced simulations.

Epistemix provides two principal products: agent-based simulation software for modelling complex human systems, and high-resolution synthetic population data that serves as realistic modelling infrastructure.

Similar companies

Repli5 logoRE

Repli5

Repli5 provides generative AI-powered synthetic data solutions to create realistic training data for computer vision applications across industries like automotive and robotics.

UniversalAGI logoUN

UniversalAGI

UniversalAGI develops foundation AI models for physics simulation and autonomous agents to automate physical systems engineering, aiming to drastically reduce simulation times for industries like aerospace and automotive.

Pathos logoPA

Pathos

Pathos is a clinical-stage biotech using AI, biological modeling, and large-scale oncology data to develop a platform for simulating and optimizing precision oncology clinical trials.

GenBio AI logoGA

GenBio AI

GenBio AI develops multiscale AI foundation models to predict, simulate, and program biology for drug discovery and healthcare applications.

AspenTech logoAS

AspenTech

AspenTech provides industrial software using AI and digital twin technology to help asset-intensive industries such as chemicals, energy, and pharmaceuticals optimise critical operations.

Buynomics logoBU

Buynomics

Buynomics provides an AI-driven platform using agent-based simulation to help enterprises optimize pricing, promotions, and product portfolios.